Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-28 @ 1:27 AM
Study NCT ID:
NCT06046534
Status:
COMPLETED
Last Update Posted:
2025-05-13
First Post:
2023-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-27
First Submit QC Date:
None
Study First Post Date:
2023-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-08
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL